Busca avançada
Ano de início
Entree


ZnO-Based Electrochemical Immunosensor to Assess Vaccine-Induced Antibody-Mediated Immunity against Wild-Type and Gamma SARS-CoV-2 Strains

Texto completo
Autor(es):
Nunez, Freddy A. ; Castro, Ana C. H. ; Daher, Isabela P. ; Cunha-Neto, Edecio ; Kalil, Jorge ; Boscardin, Silvia B. ; Lanfredi, Alexandre J. C. ; de Oliveira, Vivian L. ; Alves, Wendel A.
Número total de Autores: 9
Tipo de documento: Artigo Científico
Fonte: BIOSENSORS-BASEL; v. 13, n. 3, p. 14-pg., 2023-03-01.
Resumo

The evaluation of serological responses to COVID-19 is crucial for population-level surveillance, developing new vaccines, and evaluating the efficacy of different immunization programs. Research and development of point-of-care test technologies remain essential to improving immunity assessment, especially for SARS-CoV-2 variants that partially evade vaccine-induced immune responses. In this work, an impedimetric biosensor based on the immobilization of the recombinant trimeric wild-type spike protein (S protein) on zinc oxide nanorods (ZnONRs) was employed for serological evaluation. We successfully assessed its applicability using serum samples from spike-based COVID-19 vaccines: ChAdOx1-S (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech). Overall, the ZnONRs/ spike-modified electrode displayed accurate results for both vaccines, showing excellent potential as a tool for assessing and monitoring seroprevalence in the population. A refined outcome of this technology was achieved when the ZnO immunosensor was functionalized with the S protein from the P.1 linage (Gamma variant). Serological responses against samples from vaccinated individuals were acquired with excellent performance. Following studies based on traditional serological tests, the ZnONRs/spike immunosensor data reveal that ChAdOx1-S vaccinated individuals present significantly less antibody-mediated immunity against the Gamma variant than the BNT162b2 vaccine, highlighting the great potential of this point-of-care technology for evaluating vaccine-induced humoral immunity against different SARS-CoV-2 strains. (AU)

Processo FAPESP: 17/02317-2 - Interfaces em materiais: propriedades eletrônicas, magnéticas, estruturais e de transporte
Beneficiário:Adalberto Fazzio
Modalidade de apoio: Auxílio à Pesquisa - Temático
Processo FAPESP: 14/50867-3 - INCT 2014: Instituto Nacional de Ciência e Tecnologia de Bioanalítica
Beneficiário:Marco Aurelio Zezzi Arruda
Modalidade de apoio: Auxílio à Pesquisa - Temático